Garda Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,400
Closed -$1.89M 248
2025
Q2
$1.89M Sell
12,400
-7,500
-38% -$1.15M 0.05% 281
2025
Q1
$3.3M Buy
+19,900
New +$3.11M 0.08% 262
2024
Q4
Sell
-28,000
Closed -$4.54M 355
2024
Q3
$4.54M Buy
28,000
+25,500
+1,020% +$4.06M 0.13% 204
2024
Q2
$365K Buy
+2,500
New +$372K 0.01% 423
2024
Q1
Sell
-3,500
Closed -$549K 496
2023
Q4
$549K Sell
3,500
-25,500
-88% -$3.91M 0.05% 323
2023
Q3
$4.52M Sell
29,000
-3,500
-11% -$578K 0.21% 87
2023
Q2
$5.38M Buy
32,500
+25,500
+364% +$4.12M 0.3% 74
2023
Q1
$1.08M Sell
7,000
-22,500
-76% -$3.63M 0.05% 231
2022
Q4
$5.21M Buy
+29,500
New +$5.09M 0.29% 106

Other funds holding JNJ

Garda Capital Partners's JNJ Position: Q3 2025 in Review

Garda Capital Partners sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 1,343 shares — an estimated $205K sold.

Garda Capital Partners first reported a position in JNJ in Q1 2023 and held it in 4 quarters. The position peaked at $1.79M in Q3 2023. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Garda Capital Partners reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Garda Capital Partners sold 1,343 Johnson & Johnson shares in Q3 2025, an estimated $205K.
  • Garda Capital Partners first reported a position in Johnson & Johnson in Q1 2023 and held it in 4 quarters.
  • Garda Capital Partners's Johnson & Johnson position peaked at $1.79M in Q3 2023.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Garda Capital Partners's 13F filing for Q3 2025, filed 10 Nov 2025.